Literature DB >> 2568596

Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.

K M O'Boyle1, D E Gaitanopoulos, M Brenner, J L Waddington.   

Abstract

Nine structurally related 1-phenyl-1H-3-benzazepine derivatives and two thienopyridines were tested for agonist and antagonist properties at the adenylate cyclase-coupled D1 dopamine receptor in homogenates of the striatum of the rat. The benzazepines SK&F 77434 and SK&F 82958, both of which contain a catechol ring, were agonists; the intrinsic activity of SK&F 77434 was similar to that of SK&F 38393, whereas SK&F 82958 was a full agonist. The remaining benzazepines inhibited the stimulation of adenylate cyclase by dopamine. Antagonist potency depended on the nature of the substituent at position 7 of the benzazepine molecule, 7-halogen compounds being the most potent. The Ki values, obtained from analysis of the antagonism of dopamine-stimulated adenylate cyclase, were significantly correlated with the Ki values for displacement of D1 ligands in binding experiments. Furthermore, antagonist activity of the resolved racemic benzazepine SK&F 83566 resided almost exclusively in the R-enantiomer. The thienopyridine derivatives SK&F 89641 and SK&F 89145 were partial agonists with greater efficacies than SK&F 38393.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568596     DOI: 10.1016/0028-3908(89)90036-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

1.  Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.

Authors:  T H C Cheung; G Bezzina; C L Hampson; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2007-08-01       Impact factor: 4.530

2.  Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.

Authors:  A M Deveney; J L Waddington
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  Molecular components of striatal plasticity: the various routes of cyclic AMP pathways.

Authors:  A Rajadhyaksha; J Leveque; W Macías; A Barczak; C Konradi
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

4.  Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice.

Authors:  Jonathan S Miller; Ronald J Tallarida; Ellen M Unterwald
Journal:  Brain Res Bull       Date:  2010-03-25       Impact factor: 4.077

5.  Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats.

Authors:  S Charntikov; T Der-Ghazarian; M S Herbert; L R Horn; C B Widarma; A Gutierrez; F A Varela; S A McDougall
Journal:  Neuroscience       Date:  2011-04-02       Impact factor: 3.590

6.  Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.

Authors:  Laura J Mosher; Roberto Frau; Alessandra Pardu; Romina Pes; Paola Devoto; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

7.  Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.

Authors:  S Rosenzweig-Lipson; P Hesterberg; J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

8.  Self-administration of D1 receptor agonists by squirrel monkeys.

Authors:  D M Grech; R D Spealman; J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

9.  Evidence for a role of D1 dopamine receptors in d-amphetamine's effect on timing behaviour in the free-operant psychophysical procedure.

Authors:  T H C Cheung; G Bezzina; K Asgari; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-15       Impact factor: 4.530

10.  D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function.

Authors:  S C Cheetham; C J Kettle; K F Martin; D J Heal
Journal:  J Neural Transm Gen Sect       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.